Novel Agent NA-1 Proves That Ischemic Neuroprotection is Possible in Older Patients

Summary

The Evaluating Neuroprotection in Aneurysm Coiling Therapy trial [ENACT; NCT00728182] showed that the novel agent NA-1 may be a useful treatment for stroke and ruptured aneurysm patients.

  • Cerebrovascular Disease Clinical Trials
  • Interventional Techniques & Devices
  • Ischemia
View Full Text